Shares of Cerus Corp. (NASDAQ:CERS) saw unusually-strong trading volume on Friday . Approximately 2,597,233 shares changed hands during trading, an increase of 124% from the previous session’s volume of 1,161,189 shares.The stock last traded at $7.37 and had previously closed at $6.97.

Several equities analysts have recently weighed in on CERS shares. BTIG Research reissued a “buy” rating and set a $10.00 target price on shares of Cerus Corp. in a research report on Monday, June 20th. FBR & Co reissued a “buy” rating on shares of Cerus Corp. in a research report on Monday, May 23rd. Cantor Fitzgerald reissued a “buy” rating and set a $9.00 target price on shares of Cerus Corp. in a research report on Thursday, July 7th. Finally, Robert W. Baird reaffirmed an “outperform” rating and issued a $9.00 price objective on shares of Cerus Corp. in a research report on Wednesday, June 22nd. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Cerus Corp. has a consensus rating of “Buy” and an average target price of $8.90.

The firm has a 50 day moving average of $6.30 and a 200 day moving average of $5.84. The stock’s market capitalization is $751.64 million.

Cerus Corp. (NASDAQ:CERS) last released its earnings results on Tuesday, May 3rd. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.16) by $0.01. The firm earned $7.60 million during the quarter, compared to analyst estimates of $8.29 million. Cerus Corp.’s quarterly revenue was down 1.3% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.17) EPS. On average, equities analysts predict that Cerus Corp. will post ($0.65) earnings per share for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN increased its position in Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock valued at $30,979,000 after buying an additional 1,007,430 shares during the period. Rail Splitter Capital Management LLC increased its position in Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock valued at $5,263,000 after buying an additional 132,970 shares during the period. Stephens Inc. AR increased its position in Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock valued at $7,032,000 after buying an additional 113,238 shares during the period. Finally, California State Teachers Retirement System increased its position in Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock valued at $1,117,000 after buying an additional 3,126 shares during the period.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.